Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 10,843 | 4,417 | 20,053 | 13,870 | 8,827 |
| Depreciation Amortization | 151 | 153 | 2,433 | 1,985 | 1,369 |
| Income taxes - deferred | 160 | N/A | 90 | 128 | 82 |
| Accounts receivable | -211 | 42 | -4,309 | -2,246 | -1,438 |
| Other Working Capital | -1,583 | 1,328 | -5,031 | -3,790 | -2,212 |
| Other Operating Activity | 471 | 100 | 4,494 | 2,327 | 1,457 |
| Operating Cash Flow | $9,831 | $6,040 | $17,731 | $12,274 | $8,084 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -10,653 | -1,677 | -11,459 | 58,380 | -3,318 |
| Purchase Of Investment | N/A | N/A | N/A | -64,619 | N/A |
| Investing Cash Flow | $-10,653 | $-1,677 | $-11,459 | $-6,239 | $-3,318 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,737 | 58 | 2,571 | 2,571 | 860 |
| Common Stock Repurchased | -119 | N/A | -3,000 | -2,559 | 0 |
| Financing Cash Flow | $1,618 | $58 | $-429 | $12 | $860 |
| Beginning Cash Position | 13,177 | 13,177 | 7,334 | 7,334 | 7,334 |
| End Cash Position | 13,973 | 17,597 | 13,177 | 13,381 | 12,961 |
| Net Cash Flow | $796 | $4,421 | $5,843 | $6,047 | $5,627 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,831 | 6,040 | 17,731 | 12,274 | 8,084 |
| Free Cash Flow | 9,831 | 6,040 | 17,731 | 12,274 | 8,084 |